Who owns CENTESSA PHARMACEUTICALS PLC?
- Ticker: CNTA
- CUSIP Number: 152309100
Tip: Access positions for across all investors
Analyze quarterly positions in Centessa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Centessa Pharmaceuticals stock
Who bought or sold CENTESSA PHARMACEUTICALS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Medicxi Ventures Management | 20M | $226M | 0% | Mar 2024 |
|
| BVF | 8.8M | $70M | -4% | Dec 2023 |
|
| EcoR1 Capital | 5.6M | $45M | 0% | Dec 2023 |
|
| Vida Ventures Advisors | 3.9M | $44M | 0% | Mar 2024 |
|
| T. Rowe Price Associates | 2.5M | $20M | 0% | Dec 2023 |
|
| Octagon Capital Advisors | 2.1M | $16M | 333% | Dec 2023 |
|
| Point72 Asset Management | 1.8M | $15M | 0% | Dec 2023 |
|
| Franklin Resources | 1.1M | $8.9M | 34% | Dec 2023 |
|
| Artal Group | 1.0M | $8.1M | 100% | Dec 2023 |
|
| Tanager Wealth Management | 696k | $5.5M | 0% | Dec 2023 |
|
| Cormorant Asset Management | 562k | $4.5M | 0% | Dec 2023 |
|
| Kynam Capital Management | 443k | $3.5M | -39% | Dec 2023 |
|
| TD Asset Management | 186k | $1.5M | 0% | Dec 2023 |
|
| Citadel Advisors | 114k | $911k | 844% | Dec 2023 |
|
| Millennium Management | 43k | $338k | 100% | Dec 2023 |
|
| Bank of America Corporation | 37k | $295k | -29% | Dec 2023 |
|
| Goldman Sachs Group | 25k | $197k | 132% | Dec 2023 |
|
| Two Sigma Investments | 17k | $131k | 42% | Dec 2023 |
|
| Trexquant Investment | 14k | $114k | 100% | Dec 2023 |
|
| Jump Financial | 14k | $114k | 100% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 13k | $101k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 11k | $85k | 5% | Dec 2023 |
|
| Barclays | 6.4k | $51k | 0% | Dec 2023 |
|
| China Universal Asset Management | 6.4k | $51k | 371% | Dec 2023 |
|
| Quarry | 6.0k | $48k | 100% | Dec 2023 |
|
| Compagnie Lombard, Odier SCA | 5.8k | $46k | 0% | Dec 2023 |
|
| Cubist Systematic Strategies | 4.8k | $38k | 100% | Dec 2023 |
|
| Zurcher Kantonalbank | 2.3k | $26k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 2.0k | $16k | -29% | Dec 2023 |
|
| UBS Group | 1.6k | $13k | -40% | Dec 2023 |
|
| GAMMA Investing | 1.5k | $17k | 164% | Mar 2024 |
|
| Citigroup | 999.00 | $8.0k | 52% | Dec 2023 |
|
| Adirondack Trust | 925.00 | $11k | 0% | Mar 2024 |
|
| Global Retirement Partners | 700.00 | $7.9k | 0% | Mar 2024 |
|
| Daiwa Securities Group | 211.00 | $2.0k | 0% | Dec 2023 |
|
| Nbc Securities | 138.00 | $1.0k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 91.00 | $1.1k | 355% | Dec 2023 |
|
| Caldwell Sutter Capital | 86.00 | $971.997800 | -50% | Mar 2024 |
|
| Spire Wealth Management | 70.00 | $791.000000 | 0% | Mar 2024 |
|
Who sold out of Centessa Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Boxer Capital | Sep 2023 | 771k | $5.0M |